Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 331

1.

Autologous Haematopoietic Stem Cell Transplantation for Crohn's Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow Transplantation.

Brierley CK, Castilla-Llorente C, Labopin M, Badoglio M, Rovira M, Ricart E, Dierickx D, Vermeire S, Hasselblatt P, Finke J, Onida F, Cassinotti A, Satsangi J, Kazmi M, López-Sanromán A, Schmidt C, Farge D, Travis SPL, Hawkey CJ, Snowden JA; European Society for Blood and Marrow Transplantation [EBMT] Autoimmune Diseases Working Party [ADWP].

J Crohns Colitis. 2018 Aug 29;12(9):1097-1103. doi: 10.1093/ecco-jcc/jjy069.

3.

Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial.

Lindsay JO, Allez M, Clark M, Labopin M, Ricart E, Rogler G, Rovira M, Satsangi J, Farge D, Hawkey CJ; ASTIC trial group; European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party; European Crohn's and Colitis Organisation.

Lancet Gastroenterol Hepatol. 2017 Jun;2(6):399-406. doi: 10.1016/S2468-1253(17)30056-0. Epub 2017 Apr 6.

4.

Hematopoietic Stem Cell Transplantation in Crohn's Disease: State-of-the-Art Treatment.

Hawkey CJ.

Dig Dis. 2017;35(1-2):107-114. doi: 10.1159/000449090. Epub 2017 Feb 1. Review.

PMID:
28147358
5.

Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases?

Hawkey CJ, Hommes DW.

Gastroenterology. 2017 Feb;152(2):389-397.e2. doi: 10.1053/j.gastro.2016.11.003. Epub 2016 Nov 11.

PMID:
27845055
6.

Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT).

MacDonald TM, Hawkey CJ, Ford I, McMurray JJV, Scheiman JM, Hallas J, Findlay E, Grobbee DE, Hobbs FDR, Ralston SH, Reid DM, Walters MR, Webster J, Ruschitzka F, Ritchie LD, Perez-Gutthann S, Connolly E, Greenlaw N, Wilson A, Wei L, Mackenzie IS.

Eur Heart J. 2017 Jun 14;38(23):1843-1850. doi: 10.1093/eurheartj/ehw387. Erratum in: Eur Heart J. 2016 Dec 24;:.

7.

Stem Cell Transplantation for Refractory Crohn Disease--Reply.

Hawkey CJ, Lindsay J, Gribben J.

JAMA. 2016 Jun 21;315(23):2620-1. doi: 10.1001/jama.2016.4033. No abstract available.

PMID:
27327809
8.

Autologous Hematopoetic Stem Cell Transplantation for Refractory Crohn Disease: A Randomized Clinical Trial.

Hawkey CJ, Allez M, Clark MM, Labopin M, Lindsay JO, Ricart E, Rogler G, Rovira M, Satsangi J, Danese S, Russell N, Gribben J, Johnson P, Larghero J, Thieblemont C, Ardizzone S, Dierickx D, Ibatici A, Littlewood T, Onida F, Schanz U, Vermeire S, Colombel JF, Jouet JP, Clark E, Saccardi R, Tyndall A, Travis S, Farge D.

JAMA. 2015 Dec 15;314(23):2524-34. doi: 10.1001/jama.2015.16700.

PMID:
26670970
9.

Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.

Heap GA, So K, Weedon M, Edney N, Bewshea C, Singh A, Annese V, Beckly J, Buurman D, Chaudhary R, Cole AT, Cooper SC, Creed T, Cummings F, de Boer NK, D'Inca R, D'Souza R, Daneshmend TK, Delaney M, Dhar A, Direkze N, Dunckley P, Gaya DR, Gearry R, Gore S, Halfvarson J, Hart A, Hawkey CJ, Hoentjen F, Iqbal T, Irving P, Lal S, Lawrance I, Lees CW, Lockett M, Mann S, Mansfield J, Mowat C, Mulgrew CJ, Muller F, Murray C, Oram R, Orchard T, Parkes M, Phillips R, Pollok R, Radford-Smith G, Sebastian S, Sen S, Shirazi T, Silverberg M, Solomon L, Sturniolo GC, Thomas M, Tremelling M, Tsianos EV, Watts D, Weaver S, Weersma RK, Wesley E, Holden A, Ahmad T.

J Crohns Colitis. 2016 Feb;10(2):149-58. doi: 10.1093/ecco-jcc/jjv219. Epub 2015 Nov 29. Erratum in: J Crohns Colitis. 2017 Dec 4;11(12):1509.

PMID:
26619893
10.

The Helicobacter Eradication Aspirin Trial (HEAT): A Large Simple Randomised Controlled Trial Using Novel Methodology in Primary Care.

Dumbleton JS, Avery AJ, Coupland C, Hobbs FD, Kendrick D, Moore MV, Morris C, Rubin GP, Smith MD, Stevenson DJ, Hawkey CJ.

EBioMedicine. 2015 Jul 10;2(9):1200-4. doi: 10.1016/j.ebiom.2015.07.012. eCollection 2015 Sep.

11.

Serum REG3alpha and C-Reactive Protein Levels in Crohn's Disease Patients Undergoing Immunoablation and Autologous Hemopoetic Stem Cell Transplantation in the ASTIC Trial.

Greuter T, Lang S, Holler E, Hawkey CJ, Rogler G, Biedermann L; ASTIC trial group.

Digestion. 2015;92(2):83-9. doi: 10.1159/000437300. Epub 2015 Aug 1.

12.

Protocol of the Febuxostat versus Allopurinol Streamlined Trial (FAST): a large prospective, randomised, open, blinded endpoint study comparing the cardiovascular safety of allopurinol and febuxostat in the management of symptomatic hyperuricaemia.

MacDonald TM, Ford I, Nuki G, Mackenzie IS, De Caterina R, Findlay E, Hallas J, Hawkey CJ, Ralston S, Walters M, Webster J, McMurray J, Perez Ruiz F, Jennings CG; Members of the FAST Study Group.

BMJ Open. 2014 Jul 10;4(7):e005354. doi: 10.1136/bmjopen-2014-005354.

14.

Stem cells as treatment in inflammatory bowel disease.

Hawkey CJ.

Dig Dis. 2012;30 Suppl 3:134-9. doi: 10.1159/000342740. Epub 2013 Jan 3. Review.

PMID:
23295704
15.

Commentary: risk factors for gastrointestinal bleeding in NSAID users.

Hawkey CJ.

Aliment Pharmacol Ther. 2012 Nov;36(9):904; discussion 905. doi: 10.1111/apt.12035. No abstract available.

16.

Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease.

Subramanian V, Ramappa V, Telakis E, Mannath J, Jawhari AU, Hawkey CJ, Ragunath K.

Inflamm Bowel Dis. 2013 Feb;19(2):350-5. doi: 10.1002/ibd.23002.

PMID:
22552948
17.

Efficacy of new playback functions at reducing small-bowel wireless capsule endoscopy reading times.

Subramanian V, Mannath J, Telakis E, Ragunath K, Hawkey CJ.

Dig Dis Sci. 2012 Jun;57(6):1624-8. doi: 10.1007/s10620-012-2074-y. Epub 2012 Feb 11.

PMID:
22327240
18.

A drunk and disorderly country: a nationwide cross-sectional survey of alcohol use and misuse in Great Britain.

Craig DG, Dakkak M, Gilmore IT, Hawkey CJ, Rhodes JM, Sheron N; British Society of Gastroenterology.

Frontline Gastroenterol. 2012 Jan;3(1):57-63. doi: 10.1136/flgastro-2011-100047. Epub 2011 Oct 27. Review.

19.

Rofecoxib and clinically significant gastrointestinal events.

Bombardier C, Laine L, Day R, Hawkey CJ, Hochberg MC, Schnitzer TJ.

Am J Med Sci. 2011 Nov;342(5):438-9. doi: 10.1097/MAJ.0b013e31822f3ff4. No abstract available.

PMID:
22030845
20.

What you need to know when you prescribe a proton pump inhibitor.

Norman A, Hawkey CJ.

Frontline Gastroenterol. 2011 Oct;2(4):199-205. doi: 10.1136/flgastro-2011-100006. Epub 2011 Jun 24.

21.

Ratio of visceral to subcutaneous fat area is a biomarker of complicated Crohn's disease.

Erhayiem B, Dhingsa R, Hawkey CJ, Subramanian V.

Clin Gastroenterol Hepatol. 2011 Aug;9(8):684-687.e1. doi: 10.1016/j.cgh.2011.05.005. Epub 2011 May 13.

PMID:
21642015
22.

High definition colonoscopy vs. standard video endoscopy for the detection of colonic polyps: a meta-analysis.

Subramanian V, Mannath J, Hawkey CJ, Ragunath K.

Endoscopy. 2011 Jun;43(6):499-505. doi: 10.1055/s-0030-1256207. Epub 2011 Feb 28.

PMID:
21360420
23.

Meta-analysis: the diagnostic yield of chromoendoscopy for detecting dysplasia in patients with colonic inflammatory bowel disease.

Subramanian V, Mannath J, Ragunath K, Hawkey CJ.

Aliment Pharmacol Ther. 2011 Feb;33(3):304-12. doi: 10.1111/j.1365-2036.2010.04525.x. Epub 2010 Dec 5.

24.

A new opening for transparency.

Hawkey CJ.

Health Serv J. 2010 Sep 9;120(6223):14-5. No abstract available.

PMID:
21038559
25.

Beliefs about personal control and self-management in 30-40 year olds living with Inflammatory Bowel Disease: a qualitative study.

Cooper JM, Collier J, James V, Hawkey CJ.

Int J Nurs Stud. 2010 Dec;47(12):1500-9. doi: 10.1016/j.ijnurstu.2010.05.008. Epub 2010 Jun 19.

PMID:
20646707
26.

Welcome to Frontline Gastroenterology.

Hawkey CJ.

Frontline Gastroenterol. 2010 Apr;1(1):3. doi: 10.1136/fg.2010.001495. Epub 2010 Apr 1. No abstract available.

27.

Narrow band imaging for characterization of high grade dysplasia and specialized intestinal metaplasia in Barrett's esophagus: a meta-analysis.

Mannath J, Subramanian V, Hawkey CJ, Ragunath K.

Endoscopy. 2010 May;42(5):351-9. doi: 10.1055/s-0029-1243949. Epub 2010 Mar 3. Review.

PMID:
20200809
28.

A novel composite endpoint to evaluate the gastrointestinal effects of NSAID through the entire GI tract: introducing CSULGIE.

Hawkey CJ.

J Rheumatol. 2010 Jan;37(1):6-8. doi: 10.3899/jrheum.091207. No abstract available.

PMID:
20040636
29.

Gastroduodenal toxicity of low-dose acetylsalicylic acid: a comparison with non-steroidal anti-inflammatory drugs.

Yeomans ND, Hawkey CJ, Brailsford W, Naesdal J.

Curr Med Res Opin. 2009 Nov;25(11):2785-93. doi: 10.1185/03007990903212682. Review.

PMID:
19788350
30.

Esomeprazole for the management of upper gastrointestinal symptoms in patients who require NSAIDs: a review of the NASA and SPACE double-blind, placebo-controlled studies.

Hawkey CJ, Svedberg LE, Naesdal J, Byrne C.

Clin Drug Investig. 2009;29(10):677-87. doi: 10.2165/11317830-000000000-00000.

PMID:
19715384
31.

Predictors of gastroduodenal erosions in patients taking low-dose aspirin.

Hart J, Hawkey CJ, Lanas A, Naesdal J, Talley NJ, Thomson AB, Yeomans ND.

Aliment Pharmacol Ther. 2010 Jan;31(1):143-9. doi: 10.1111/j.1365-2036.2009.04133.x.

32.

NSAIDs and aspirin: notorious or FAMOUS?

Hawkey CJ.

Lancet. 2009 Jul 11;374(9684):93-4. doi: 10.1016/S0140-6736(09)61245-9. Epub 2009 Jul 3. No abstract available.

PMID:
19577799
33.

Induction of a chemoattractant transcriptional response by a Campylobacter jejuni boiled cell extract in colonocytes.

Mellits KH, Connerton IF, Loughlin MF, Clarke P, Smith J, Dillon E, Connerton PL, Mulholland F, Hawkey CJ.

BMC Microbiol. 2009 Feb 4;9:28. doi: 10.1186/1471-2180-9-28.

34.

Disruption of colonic barrier function and induction of mediator release by strains of Campylobacter jejuni that invade epithelial cells.

Beltinger J, del Buono J, Skelly MM, Thornley J, Spiller RC, Stack WA, Hawkey CJ.

World J Gastroenterol. 2008 Dec 28;14(48):7345-52.

35.

Assessing bleeds clinically: what's the score?

Subramanian V, Hawkey CJ.

Lancet. 2009 Jan 3;373(9657):5-7. doi: 10.1016/S0140-6736(08)61770-5. Epub 2008 Dec 16. No abstract available.

PMID:
19091391
36.

The role of stem cell transplantation in inflammatory bowel disease.

Fortun PJ, Hawkey CJ.

Autoimmunity. 2008 Dec;41(8):654-9. doi: 10.1080/08916930802197826. Review. No abstract available.

PMID:
18958747
37.

Comparison of high-resolution magnification narrow-band imaging and white-light endoscopy in the prediction of histology in Barrett's oesophagus.

Singh R, Karageorgiou H, Owen V, Garsed K, Fortun PJ, Fogden E, Subramaniam V, Shonde A, Kaye P, Hawkey CJ, Ragunath K.

Scand J Gastroenterol. 2009;44(1):85-92. doi: 10.1080/00365520802400818.

PMID:
18821132
38.

Clinical trial: a randomized trial of early endoscopy, Helicobacter pylori testing and empirical therapy for the management of dyspepsia in primary care.

Duggan AE, Elliott CA, Miller P, Hawkey CJ, Logan RF.

Aliment Pharmacol Ther. 2009 Jan;29(1):55-68. doi: 10.1111/j.1365-2036.2008.03852.x. Epub 2008 Sep 17.

39.

Guest authorship, mortality reporting, and integrity in rofecoxib studies.

Hawkey CJ.

JAMA. 2008 Aug 27;300(8):901; author reply 904-5. doi: 10.1001/jama.300.8.901-b. No abstract available.

PMID:
18728257
40.

Safer NSAID strategies: consensus or contentious?

Hawkey CJ.

Rheumatology (Oxford). 2008 Sep;47(9):1265-6. doi: 10.1093/rheumatology/ken229. Epub 2008 Jul 8. No abstract available.

PMID:
18611921
41.

Optical Microangiography: High-Definition Magnification Colonoscopy with Narrow Band Imaging (NBI) for Visualizing Mucosal Capillaries and Red Blood Cells in the Large Intestine.

Yao K, Anagnostopoulos GK, Jawhari AU, Kaye PV, Hawkey CJ, Ragunath K.

Gut Liver. 2008 Jun;2(1):14-8. doi: 10.5009/gnl.2008.2.1.14. Epub 2008 Jun 30.

42.

Narrow-band imaging with magnification in Barrett's esophagus: validation of a simplified grading system of mucosal morphology patterns against histology.

Singh R, Anagnostopoulos GK, Yao K, Karageorgiou H, Fortun PJ, Shonde A, Garsed K, Kaye PV, Hawkey CJ, Ragunath K.

Endoscopy. 2008 Jun;40(6):457-63. doi: 10.1055/s-2007-995741. Epub 2008 May 6.

PMID:
18459090
43.

Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole.

Hawkey CJ, Ell C, Simon B, Albert J, Keuchel M, McAlindon M, Fortun P, Schumann S, Bolten W, Shonde A, Hugot JL, Yu V, Arulmani U, Krammer G, Rebuli R, Toth E.

Clin Gastroenterol Hepatol. 2008 May;6(5):536-44. doi: 10.1016/j.cgh.2007.12.023. Epub 2008 Jan 31.

PMID:
18242145
44.

Clinical trial: comparison of the gastrointestinal safety of lumiracoxib with traditional nonselective nonsteroidal anti-inflammatory drugs early after the initiation of treatment--findings from the Therapeutic Arthritis Research and Gastrointestinal Event Trial.

Hawkey CJ, Weinstein WM, Stricker K, Murphy V, Richard D, Krammer G, Rebuli R.

Aliment Pharmacol Ther. 2008 May;27(9):838-45. doi: 10.1111/j.1365-2036.2008.03622.x. Epub 2008 Jan 22.

45.

Clinical trial: healing of NSAID-associated gastric ulcers in patients continuing NSAID therapy - a randomized study comparing ranitidine with esomeprazole.

Goldstein JL, Johanson JF, Hawkey CJ, Suchower LJ, Brown KA.

Aliment Pharmacol Ther. 2007 Oct 15;26(8):1101-11.

46.

Novel endoscopic observation in Barrett's oesophagus using high resolution magnification endoscopy and narrow band imaging.

Anagnostopoulos GK, Yao K, Kaye P, Hawkey CJ, Ragunath K.

Aliment Pharmacol Ther. 2007 Aug 1;26(3):501-7.

47.

A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn's disease.

Mansfield JC, Parkes M, Hawthorne AB, Forbes A, Probert CS, Perowne RC, Cooper A, Zeldis JB, Manning DC, Hawkey CJ.

Aliment Pharmacol Ther. 2007 Aug 1;26(3):421-30.

48.

Effect of risk factors on complicated and uncomplicated ulcers in the TARGET lumiracoxib outcomes study.

Hawkey CJ, Weinstein WM, Smalley W, Gitton X, Sallstig P, Stricker K, Krammer G, Mellein B, Richard D, Matchaba P.

Gastroenterology. 2007 Jul;133(1):57-64. Epub 2007 Apr 27.

PMID:
17631131
49.

Consuming broccoli does not induce genes associated with xenobiotic metabolism and cell cycle control in human gastric mucosa.

Gasper AV, Traka M, Bacon JR, Smith JA, Taylor MA, Hawkey CJ, Barrett DA, Mithen RF.

J Nutr. 2007 Jul;137(7):1718-24.

PMID:
17585021
50.

Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies.

Hawkey CJ, Talley NJ, Scheiman JM, Jones RH, Långström G, Naesdal J, Yeomans ND; NASA/SPACE author group.

Arthritis Res Ther. 2007;9(1):R17.

Supplemental Content

Loading ...
Support Center